Literature DB >> 20534903

Functional haplotypes in the promoter region of transcription factor Nrf2 in chronic obstructive pulmonary disease.

Chung-Ching Hua1, Liang-Che Chang, Jo-Chi Tseng, Chien-Ming Chu, Yu-Chih Liu, Wen-Bin Shieh.   

Abstract

Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protects against oxidative stress which is important in the pathogenesis of chronic obstructive pulmonary disease (COPD). Three single nucleotide polymorphisms and 1 triplet repeat polymorphism are found in the promoter region of the Nrf2 gene. Molecular haplotyping of the Nrf2 promoter region was performed using DNA obtained from the peripheral blood of 69 COPD patients. The luciferase activities of Nrf2 promoter constructs containing all possible combinations of the 4 polymorphisms were determined and found to differ among the 16 haplotypes.The haplotypes isolated from the subjects were divided into 3 groups (L: low; M: medium; H: high) on the basis of luciferase activities. The proportions of subjects belonging to global initiative for chronic obstructive lung disease stage 3 or 4 decreased from the group with the LL haplotype to that with the HH haplotype. Presence of the LH or MM haplotype (hazard ratio, 3.36; 95% confidence interval, 1.16-9.69), gender (0.13; 0.02-0.67), and post-bronchodilator FEV1 value of predicted (0.95; 0.91-0.99) are significant predictors of respiratory failure development.The haplotype of the Nrf2 gene promoter affects its activity, and is associated with the severity and the development of respiratory failure in COPD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534903      PMCID: PMC3833611          DOI: 10.3233/DMA-2010-0700

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  15 in total

1.  Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis.

Authors:  Yashoda M Hosakote; Paul D Jantzi; Dana L Esham; Heidi Spratt; Alexander Kurosky; Antonella Casola; Roberto P Garofalo
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

Review 2.  Environmental pollutants and the immune response.

Authors:  Takafumi Suzuki; Takanori Hidaka; Yoshito Kumagai; Masayuki Yamamoto
Journal:  Nat Immunol       Date:  2020-10-12       Impact factor: 25.606

3.  A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.

Authors:  Asim Alam; Nitai D Mukhopadhyay; Yi Ning; Leonid B Reshko; Robert J G Cardnell; Omair Alam; Christopher S Rabender; Vasily A Yakovlev; Linda Walker; Mitchell S Anscher; Ross B Mikkelsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-06       Impact factor: 7.038

Review 4.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

Review 5.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

6.  Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.

Authors:  Caroline Ran; Karin Wirdefeldt; Lovisa Brodin; Mehrafarin Ramezani; Marie Westerlund; Fengqing Xiang; Anna Anvret; Thomas Willows; Olof Sydow; Anders Johansson; Dagmar Galter; Per Svenningsson; Andrea Carmine Belin
Journal:  Parkinsons Dis       Date:  2017-05-02

7.  RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.

Authors:  Jiyoun Yeo; Diego A Morales; Tian Chen; Erin L Crawford; Xiaolu Zhang; Thomas M Blomquist; Albert M Levin; Pierre P Massion; Douglas A Arenberg; David E Midthun; Peter J Mazzone; Steven D Nathan; Ronald J Wainz; Patrick Nana-Sinkam; Paige F S Willey; Taylor J Arend; Karanbir Padda; Shuhao Qiu; Alexei Federov; Dawn-Alita R Hernandez; Jeffrey R Hammersley; Youngsook Yoon; Fadi Safi; Sadik A Khuder; James C Willey
Journal:  BMC Pulm Med       Date:  2018-03-05       Impact factor: 3.317

8.  Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse.

Authors:  Kemper Nunes Dos Santos; Rodrigo M Florentino; Andressa França; Antônio Carlos Melo Lima Filho; Marcone Loiola Dos Santos; Dabny Missiaggia; Matheus de Castro Fonseca; Igor Brasil Costa; Paula Vieira Teixeira Vidigal; Michael H Nathanson; Fernanda de Oliveira Lemos; M Fatima Leite
Journal:  Int J Mol Sci       Date:  2019-07-23       Impact factor: 5.923

Review 9.  Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2.

Authors:  Hye-Youn Cho
Journal:  Oxid Med Cell Longev       Date:  2013-07-10       Impact factor: 6.543

10.  Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.

Authors:  Edyta Reszka; Zbigniew Jablonowski; Edyta Wieczorek; Ewa Jablonska; Magdalena Beata Krol; Jolanta Gromadzinska; Adam Grzegorczyk; Marek Sosnowski; Wojciech Wasowicz
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.